110
Participants
Start Date
September 7, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
January 31, 2026
Medical Cannabis
Participants will be restricted to specific medical cannabis products from Ethos Dispensary. They will be randomized to one medical cannabis formulation (tincture or vaporization) for the duration of the study. Each month for three months, they will purchase a different composition (predominantly THC, predominantly CBD, or balanced products) of their designated formulation. The order of compositions will be randomized and double-blinded, so participants and the research team will not know which compositions of medical cannabis they are using each month.
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
Thomas Jefferson University
OTHER